


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app42.us.archive.org';v.server_ms=901;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Intrauterine growth restriction: screening, diagnosis, and management. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712211245im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712211245im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712211245im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712211245im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712211245/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712211245im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712211245cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712211245js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712211245if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712211245/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712211245if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712211245/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712211245/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712211245/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712211245/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712211245/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712211245/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712211245/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712211245/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712211245/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712211245/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712211245/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712211245/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712211245/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712211245/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712211245/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712211245/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712211245/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712211245/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712211245/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712211245/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010012</li>
            <li>2013 Aug
            </li>            
                                </ul>
        <div>
                <h1>Intrauterine growth restriction: screening, diagnosis, and management.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712211245/https://www.guideline.gov/search?f_Guideline_Developer_String=Society%20of%20Obstetricians%20and%20Gynaecologists%20of%20Canada&amp;fLockTerm=Society%2Bof%2BObstetricians%2Band%2BGynaecologists%2Bof%2BCanada">Society of Obstetricians and Gynaecologists of Canada</a></li>
                        <li>   
                                <a id="581" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Lausman A, Kingdom J, Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013 Aug;35(8):741-8. [55 references] <a href="https://web.archive.org/web/20180712211245/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=24007710" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712211245im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table>                    <p><a href="/web/20180712211245/https://www.guideline.gov/Home/Disclaimer?id=47083&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fsogc.org%252fguidelines%252fintrauterine-growth-restriction-screening-diagnosis-management%252f">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712211245im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712211245/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712211245/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_ICD9CM_CUI=C0015934&amp;fLockTerm=Fetal+growth+retardation%2c+unspecified%2c+unspecified+%5bweight%5d">Fetal growth retardation, unspecified, unspecified [weight]</a>
 (764.90), <a href="/web/20180712211245/https://www.guideline.gov/search?f_ICD9CM_CUI=C0411178&amp;fLockTerm=Maternal+infections+affecting+fetus+or+newborn">Maternal infections affecting fetus or newborn</a>
 (760.2)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0001617&amp;fLockTerm=Adrenal+Cortex+Hormones">Adrenal Cortex Hormones</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0002938&amp;fLockTerm=Aneuploidy">Aneuploidy</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0004057&amp;fLockTerm=Aspirin">Aspirin</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0007208&amp;fLockTerm=Cardiotocography">Cardiotocography</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0009450&amp;fLockTerm=Communicable+Diseases">Communicable Diseases</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0011209&amp;fLockTerm=Delivery%2c+Obstetric">Delivery, Obstetric</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0015934&amp;fLockTerm=Fetal+Growth+Retardation">Fetal Growth Retardation</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0751992&amp;fLockTerm=Fetal+Weight">Fetal Weight</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0025084&amp;fLockTerm=Medical+History+Taking">Medical History Taking</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0032972&amp;fLockTerm=Pregnancy+Outcome">Pregnancy Outcome</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0033052&amp;fLockTerm=Prenatal+Care">Prenatal Care</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0033053&amp;fLockTerm=Prenatal+Diagnosis">Prenatal Diagnosis</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0034928&amp;fLockTerm=Referral+and+Consultation">Referral and Consultation</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0085134&amp;fLockTerm=Smoking+Cessation">Smoking Cessation</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0080265&amp;fLockTerm=Ultrasonography%2c+Prenatal">Ultrasonography, Prenatal</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MSH_CUI=C0041637&amp;fLockTerm=Umbilical+Veins">Umbilical Veins</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0001617&amp;fLockTerm=Adrenal+Cortex+Hormones">Adrenal Cortex Hormones</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0203043&amp;fLockTerm=Amniography">Amniography</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0004057&amp;fLockTerm=Aspirin">Aspirin</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0007208&amp;fLockTerm=Cardiotocography">Cardiotocography</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0085134&amp;fLockTerm=Cessation+of+smoking">Cessation of smoking</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0009450&amp;fLockTerm=Communicable+Diseases">Communicable Diseases</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0015934&amp;fLockTerm=Fetal+Growth+Retardation">Fetal Growth Retardation</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0011209&amp;fLockTerm=Obstetric+Delivery">Obstetric Delivery</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C2173597&amp;fLockTerm=obstetric+ultrasound%3a+estimated+fetal+weight">obstetric ultrasound: estimated fetal weight</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0033052&amp;fLockTerm=Prenatal+care">Prenatal care</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C1621885&amp;fLockTerm=Smoking+cessation+education">Smoking cessation education</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C1288338&amp;fLockTerm=Structure+of+ductus+venosus">Structure of ductus venosus</a>
, <a href="/web/20180712211245/https://www.guideline.gov/search?f_MTH_CUI=C0041637&amp;fLockTerm=Umbilical+vein">Umbilical vein</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_PDQ_CUI=C0004057&amp;fLockTerm=acetylsalicyclic+acid">acetylsalicyclic acid</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001617&amp;fLockTerm=Adrenal+cortex+hormone">Adrenal cortex hormone</a>
 (21568003), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0001617&amp;fLockTerm=Adrenal+cortex+hormone">Adrenal cortex hormone</a>
 (79440004), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002938&amp;fLockTerm=Aneuploidy">Aneuploidy</a>
 (80056000), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0033052&amp;fLockTerm=Antenatal+care">Antenatal care</a>
 (424525001), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0004057&amp;fLockTerm=Aspirin">Aspirin</a>
 (387458008), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0004057&amp;fLockTerm=Aspirin">Aspirin</a>
 (7947003), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009450&amp;fLockTerm=Communicable+disease">Communicable disease</a>
 (189822004), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009450&amp;fLockTerm=Communicable+disease">Communicable disease</a>
 (191415002), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009450&amp;fLockTerm=Communicable+disease">Communicable disease</a>
 (40733004), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011209&amp;fLockTerm=Delivery+-+action">Delivery - action</a>
 (236973005), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011209&amp;fLockTerm=Delivery+-+action">Delivery - action</a>
 (360149000), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1960969&amp;fLockTerm=Doppler+ultrasound+scan+of+middle+cerebral+artery+of+fetus">Doppler ultrasound scan of middle cerebral artery of fetus</a>
 (425813003), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1960968&amp;fLockTerm=Fetal+biometry+using+ultrasound">Fetal biometry using ultrasound</a>
 (426840007), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015934&amp;fLockTerm=Fetal+growth+restriction">Fetal growth restriction</a>
 (22033007), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0411178&amp;fLockTerm=Fetal+or+neonatal+effect+of+maternal+infection">Fetal or neonatal effect of maternal infection</a>
 (206005002), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1960015&amp;fLockTerm=Obstetric+umbilical+artery+Doppler">Obstetric umbilical artery Doppler</a>
 (427623005), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1961018&amp;fLockTerm=Obstetric+uterine+artery+Doppler">Obstetric uterine artery Doppler</a>
 (426295007), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1621885&amp;fLockTerm=Smoking+cessation+education">Smoking cessation education</a>
 (225323000), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1288338&amp;fLockTerm=Structure+of+ductus+venosus">Structure of ductus venosus</a>
 (367624001), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041637&amp;fLockTerm=Structure+of+umbilical+vein">Structure of umbilical vein</a>
 (367567000), <a href="/web/20180712211245/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0203043&amp;fLockTerm=Ultrasound+scan+for+amniotic+fluid+volume">Ultrasound scan for amniotic fluid volume</a>
 (241494004)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_SPN_CUI=C0183135&amp;fLockTerm=IMAGER%2c+ULTRASONIC+OBSTETRIC-GYNECOLOGIC">IMAGER, ULTRASONIC OBSTETRIC-GYNECOLOGIC</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712211245/https://www.guideline.gov/search?f_UMD_CUI=C0183135&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic%2c+Obstetric%2fGynecologic">Scanning Systems, Ultrasonic, Obstetric/Gynecologic</a>
 (15-657)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/downloadcontent/ngc-10012?contentType=pdf" class="pdf">.PDF 91.9 kb</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/downloadcontent/ngc-10012?contentType=word" class="word">Word Document 286.8 kb</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/downloadcontent/ngc-10012?contentType=xml" class="xml">.XML 36.1 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712211245/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/47083/intrauterine-growth-restriction-screening-diagnosis-and-management" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712211245/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/47083/intrauterine-growth-restriction-screening-diagnosis-and-management" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712211245/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/47083/intrauterine-growth-restriction-screening-diagnosis-and-management&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712211245/mailto:/?Subject=AHRQ: Intrauterine growth restriction: screening, diagnosis, and management.&amp;body=https://www.guideline.gov/summaries/summary/47083/intrauterine-growth-restriction-screening-diagnosis-and-management" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Intrauterine growth restriction: screening, diagnosis, and management. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Aug 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083">RefWorks</a></li>
                            <li><a href="/web/20180712211245/https://www.guideline.gov/summaries/citedownload/47083?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="47083" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The quality of evidence (<strong>I-III</strong>) and classification of recommendations (<strong>A-E, L</strong>) are defined at the end of the "Major Recommendations" field.</p>
<p><strong>Summary Statements</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>The definition of small-for-gestational age for a fetus in utero is an estimated fetal weight that measures &lt;10th percentile on ultrasound. This diagnosis does not necessarily imply pathologic growth abnormalities, and may simply describe a fetus at the lower end of the normal range. (<strong>III</strong>) </li>
    <li>Intrauterine growth restriction (IUGR) refers to a fetus with an estimated fetal weight &lt;10th percentile on ultrasound that, because of a pathologic process, has not attained its biologically determined growth potential. (<strong>III</strong>) A clinical estimation of fetal weight or symphysis-fundal height has poor sensitivity and specificity and should not be relied upon to diagnose IUGR. IUGR should be considered in the differential diagnosis when the fetus is found to be small for gestational age. (<strong>II-1</strong>) </li>
    <li>Effective screening for IUGR requires accurate dating and includes a review of the mother's menstrual history, relevant assisted reproductive technology information, and either a first trimester or early second trimester dating ultrasound. (<strong>I</strong>) </li>
    <li>Symphysis-fundal height determination is of limited value in routine obstetrical care, but continues to be the only physical examination screening test available. (<strong>I</strong>) </li>
    <li>Fetal weight determination in fetuses between the 10th and 90th percentiles by ultrasound biometry alone has at least a 10% error rate across gestation, but is effective equally when measuring with abdominal circumference alone or in combination with head size (biparietal diameter or head circumference) and/or femur length to establish an estimated fetal weight. (<strong>II-2</strong>) </li>
    <li>Determining whether IUGR is symmetric or asymmetric is of less clinical importance than careful re-evaluation of fetal anatomy and uterine and umbilical artery Doppler studies. (<strong>I</strong>) </li>
    <li>In women with risk factors for IUGR, uterine artery Doppler screening at 19 to 23 weeks may identify pregnancies at risk of antepartum stillbirth and preterm delivery due to IUGR and placental disease. (<strong>II-2</strong>) </li>
    <li>In pregnancies in which IUGR due to uteroplacental vascular insufficiency is diagnosed, maternal surveillance for the development of severe preeclampsia with adverse features is warranted. (<strong>II-1</strong>) </li>
    <li>Once surveillance of a fetus with IUGR is instituted, umbilical artery Doppler studies and biophysical profile scoring can be used as short-term predictors of fetal well-being. (<strong>I</strong>) </li>
    <li>In the presence of abnormal umbilical artery Doppler studies, further investigation of the fetal circulatory system by Doppler examination of the middle cerebral artery, ductus venosus, and umbilical vein can be considered. (<strong>II-2</strong>) </li>
    <li>For a fetus with IUGR, the decision for obstetrical intervention, including Caesarean section, in cases of abnormal fetal heart rate or malpresentation is largely based on fetal viability, as assessed by ultrasound. (<strong>II-2</strong>) </li>
    <li>Maternal surveillance for the development of preeclampsia is warranted. (<strong>II-2</strong>) </li>
</ol>
<p><strong>Recommendations</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Women should be screened for clinical risk factors for IUGR by means of a complete history. (<strong>II-2B</strong>) </li>
    <li>Women should be counseled on smoking cessation at any time during pregnancy. (<strong>II-2A</strong>) </li>
    <li>First and second trimester screening tests for aneuploidy maybe useful tests of placental function. If two screening test results are abnormal, health care providers should be aware that the fetus is at increased risk of preterm IUGR and associated stillbirth. (<strong>II-1A</strong>) </li>
    <li>If IUGR is suspected, further assessment can assist in making the diagnosis. If available, detailed ultrasound examination of the placenta (looking for evidence of a small, thickened placenta, or abnormal morphology) and uterine artery Dopplers should be considered at 19 to 23 weeks. In the absence of available diagnostic testing, closer surveillance should be offered. A maternal-fetal medicine consultation can be considered if the placenta appears abnormal on ultrasound, especially in the context of a growth-restricted fetus and abnormal uterine artery Doppler. In a rural setting, the caregiver needs to decide whether the patient should be delivered immediately, or whether transfer to a tertiary center is appropriate. A telephone consultation and telemedicine may help. (<strong>II-2A</strong>) </li>
    <li>In women without risk factors for IUGR, comprehensive third trimester ultrasound examination including biophysical profile, fetal biometry, amniotic fluid volume, and umbilical artery Doppler studies is not recommended. (<strong>II-2D</strong>) </li>
    <li>Low-dose aspirin should be recommended to women with a previous history of placental insufficiency syndromes including IUGR and preeclampsia. It should be initiated between 12 and 16 weeks' gestation and continued until 36 weeks. (<strong>I-A</strong>) </li>
    <li>Low-dose aspirin should also be recommended to women with two or more current risk factors in pregnancy including, but not limited to, pre-gestational hypertension, obesity, maternal age &gt;40 years, history of use of artificial reproductive technology, pre-gestational diabetes mellitus (type I or II), multiple gestation, previous history of placental abruption, and previous history of placental infarction. It should be initiated between 12 and 16 weeks' gestation and continued until 36 weeks. (<strong>I-A</strong>) </li>
    <li>Umbilical artery Doppler studies are not recommended as a routine screening test in uncomplicated pregnancies. (<strong>I-E</strong>) </li>
    <li>An ultrasound examination for estimated fetal weight and amniotic fluid volume should be considered after 26 weeks if the symphysis-fundal height measurement in centimeters deviates by 3 or more from the gestational age in weeks or there is a plateau in symphysis-fundal height. (<strong>II-2B</strong>) </li>
    <li>In cases in which the fetus measures &lt;10th percentile by estimated fetal weight or abdominal circumference measurement, the underlying cause of IUGR may be established by an enhanced ultrasound examination to include a detailed review of fetal anatomy, placental morphology, and Doppler studies of the uterine and umbilical arteries. (<strong>II-2A</strong>) </li>
    <li>In cases of IUGR, determination of amniotic fluid volume should be performed to aid in the differential diagnosis of IUGR and increase the accuracy of the diagnosis of placental insufficiency. (<strong>II-2B</strong>) </li>
    <li>Umbilical artery Doppler should be performed in all fetuses with an estimated fetal weight or an abdominal circumference &lt;10th percentile. (<strong>I-A</strong>) </li>
    <li>In pregnancies affected by IUGR, umbilical artery Doppler studies after 24 weeks may prompt intervention that reduces perinatal mortality and severe perinatal morbidity due to IUGR. (<strong>I-A</strong>) </li>
    <li>In pregnancies in which IUGR has been identified, invasive testing to rule out aneuploidy may be offered where fetal abnormalities are suspected, soft markers are seen, or no supportive evidence of underlying placental insufficiency is evident. (<strong>II-2A</strong>) </li>
    <li>In patients presenting with IUGR, maternal screening for infectious etiology may be considered. (<strong>II-2A</strong>) </li>
    <li>When IUGR is diagnosed, surveillance should be initiated. Serial ultrasound estimation of fetal weight (every 2 weeks), along with umbilical artery Doppler studies should be initiated. If available, a placental assessment and other Doppler studies such as middle cerebral artery, umbilical vein, and ductus venosus can be performed. Increased frequency of surveillance may be required. (<strong>II-2A</strong>) </li>
    <li>If fetal growth starts to plateau, amniotic fluid index starts to decline, or fetal tone or gross movements are diminished or absent, then more intensive surveillance (e.g., 2 to 3 times per week) or admission to hospital and delivery planning is required. (<strong>II-2A</strong>) </li>
    <li>Abnormal umbilical cord Doppler (e.g., absent or reversed end-diastolic flow) in the presence of IUGR is an ominous finding that requires intervention and possible delivery. (<strong>I-A</strong>) </li>
    <li>Cardiotocography (non-stress testing) performed antenatally as a test of fetal well-being should not be used in isolation to monitor fetuses with IUGR. (<strong>II-2E</strong>) </li>
    <li>Maternal administration of corticosteroids is indicated if there is a significant possibility of delivery at &lt;34 weeks' gestation, as administration may positively affect umbilical Doppler studies. (<strong>I-A</strong>) </li>
    <li>If delivery was not indicated prior to 37 weeks in a patient diagnosed with IUGR, expectant management with close fetal and maternal surveillance versus delivery should be discussed after 37 weeks. (<strong>I-A</strong>) </li>
    <li>Site of planned delivery should take into consideration facilities and expertise available at each institution including obstetricians, pediatricians or neonatologists as appropriate, anesthesiologists, and access to Caesarean section. (<strong>III-A</strong>) </li>
</ol>
<p><span style="text-decoration: underline;"><strong>Definitions</strong></span>:</p>
<p><strong>Quality of Evidence Assessment*</strong></p>
<p><strong>I</strong>: Evidence obtained from at least one properly randomized controlled trial</p>
<p><strong>II-1</strong>: Evidence from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong>: Evidence from well-designed cohort (prospective or retrospective) or case-control studies, preferably from more than one centre or research group</p>
<p><strong>II-3</strong>: Evidence obtained from comparisons between times or places with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of treatment with penicillin in the 1940s) could also be included in this category</p>
<p><strong>III</strong>: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p>
<p class="Note">*Adapted from the Evaluation of Evidence criteria described in the Canadian Task Force on Preventive Health Care.</p>
<p><strong>Classification of Recommendations&dagger;</strong></p>
<p><strong>A.</strong> There is good evidence to recommend the clinical preventive action</p>
<p><strong>B.</strong> There is fair evidence to recommend the clinical preventive action</p>
<p><strong>C.</strong> The existing evidence is conflicting and does not allow to make a recommendation for or against use of the clinical preventive action; however, other factors may influence decision-making</p>
<p><strong>D.</strong> There is fair evidence to recommend against the clinical preventive action</p>
<p><strong>E.</strong> There is good evidence to recommend against the clinical preventive action</p>
<p><strong>L.</strong> There is insufficient evidence (in quantity or quality) to make a recommendation; however, other factors may influence decision-making</p>
<p class="Note">&dagger;Adapted from the Classification of Recommendations criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Intrauterine growth restriction</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Counseling</p>
                    <p>Diagnosis</p>
                    <p>Management</p>
                    <p>Risk Assessment</p>
                    <p>Screening</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Obstetrics and Gynecology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To provide summary statements and recommendations and to establish a framework for screening, diagnosis, and management of pregnancies affected with intrauterine growth restriction (IUGR)</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Pregnant women with clinical risk factors for intrauterine growth restriction (IUGR) or with a confirmed diagnosis of IUGR</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>Screening for clinical risk factors for intrauterine growth restriction (IUGR) by means of a complete history </li>
    <li>Counseling on smoking cessation at any time during pregnancy </li>
    <li>First and second trimester screening tests for aneuploidy </li>
    <li>Ultrasound examination of the placenta and uterine artery Dopplers at 19 to 23 weeks </li>
    <li>Maternal&ndash;fetal medicine consultation </li>
    <li>Comprehensive third trimester ultrasound examination including biophysical profile, fetal biometry, amniotic fluid volume, and umbilical artery Doppler studies (not recommended in women without risk factors for IUGR) </li>
    <li>Low-dose aspirin in at-risk women </li>
    <li>Invasive testing to rule out aneuploidy </li>
    <li>Maternal screening for infectious etiology </li>
    <li>Surveillance of IUGR, including serial ultrasound estimation of fetal weight, umbilical artery Doppler studies, placental assessment, and other Doppler studies such as middle cerebral artery, umbilical vein, and ductus venosus </li>
    <li>Increased surveillance (e.g., 2 to 3 times per week) or admission to hospital and delivery planning as required </li>
    <li>Antenatal cardiotocography (non-stress testing) as a test of fetal well-being (not recommended in isolation to monitor fetuses with IUGR) </li>
    <li>Maternal administration of corticosteroids </li>
    <li>Expectant management with close fetal and maternal surveillance versus delivery after 37 weeks </li>
    <li>Choosing site of planned delivery, taking into consideration facilities and expertise available </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Risk of intrauterine growth restriction (IUGR) and stillbirth in the third trimester </li>
    <li>Perinatal morbidity and mortality </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Searches of Electronic Databases</p>
                    <p>Searches of Unpublished Data</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>Published literature in English was retrieved through searches of PubMed or MEDLINE, CINAHL, and The Cochrane Library in January 2013 using appropriate controlled vocabulary via MeSH terms (fetal growth restriction and small for gestational age) and key words (fetal growth, restriction, growth retardation, IUGR, low birth weight, small for gestational age). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Quality of Evidence Assessment*</strong></p>
<p><strong>I</strong>: Evidence obtained from at least one properly randomized controlled trial</p>
<p><strong>II-1</strong>: Evidence from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong>: Evidence from well-designed cohort (prospective or retrospective) or case-control studies, preferably from more than one centre or research group</p>
<p><strong>II-3</strong>: Evidence obtained from comparisons between times or places with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of treatment with penicillin in the 1940s) could also be included in this category</p>
<p><strong>III</strong>: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p>
<p class="Note">*Adapted from The Evaluation of Evidence criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (see the "Rating Scheme for the Strength of the Evidence" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Classification of Recommendations&dagger;</strong></p>
<p><strong>A.</strong> There is good evidence to recommend the clinical preventive action</p>
<p><strong>B.</strong> There is fair evidence to recommend the clinical preventive action</p>
<p><strong>C.</strong> The existing evidence is conflicting and does not allow to make a recommendation for or against use of the clinical preventive action; however, other factors may influence decision-making</p>
<p><strong>D.</strong> There is fair evidence to recommend against the clinical preventive action</p>
<p><strong>E.</strong> There is good evidence to recommend against the clinical preventive action</p>
<p><strong>L.</strong> There is insufficient evidence (in quantity or quality) to make a recommendation; however, other factors may influence decision-making</p>
<p class="Note">&dagger;Adapted from the Classification of Recommendations criteria described in the Canadian Task Force on Preventive Health Care.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>This clinical practice guideline has been prepared by the Maternal Fetal Medicine Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Implementation of the recommendations in this guideline should increase clinician recognition of intrauterine growth restriction (IUGR) and guide intervention where appropriate. Optimal long-term follow-up of neonates diagnosed as IUGR may improve their long-term health.</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>This document reflects emerging clinical and scientific advances on the date issued and is  subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be reproduced in any form without prior written permission of the Society of Obstetricians and Gynaecologists of Canada (SOGC).</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Foreign Language Translations</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Lausman A, Kingdom J, Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can. 2013 Aug;35(8):741-8. [55 references] <a href="https://web.archive.org/web/20180712211245/http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=24007710" target="_blank">PubMed</a> <img alt="External Web Site Policy" src="/web/20180712211245im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2013 Aug</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>Society of Obstetricians and Gynaecologists of Canada</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Maternal Fetal Medicine Committee</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Principal Authors</em>: Andrea Lausman, MD, Toronto ON; John Kingdom, MD, Toronto ON</p>
<p><em>Maternal Fetal Medicine Committee</em>: Robert Gagnon, MD (<em>Chair</em>), Verdun QC; Melanie Basso, RN, Vancouver BC; Hayley Bos, MD, London ON; Joan Crane, MD, St. John's NL; Gregory Davies, MD, Kingston ON; Marie-France Delisle, MD, Vancouver BC; Lynda Hudon, MD, Montreal QC; Savas Menticoglou, MD, Winnipeg MB; William Mundle, MD, Windsor ON; Annie Ouellet, MD, Sherbrooke QC; Tracy Pressey, MD, Vancouver BC; Christy Pylypjuk, MD, Saskatoon SK; Anne Roggensack, MD, Calgary AB; Frank Sanderson, MD, Saint John NB</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Disclosure statements have been received from all members of the committee.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Electronic copies: Available from the <a href="/web/20180712211245/https://www.guideline.gov/Home/Disclaimer?id=47083&amp;contentType=summary&amp;redirect=http%3a%2f%2fsogc.org%2fguidelines%2fintrauterine-growth-restriction-screening-diagnosis-management%2f" title="Society of Obstetricians and Gynaecologists of Canada (SOGC) Web site">Society of Obstetricians and Gynaecologists of Canada (SOGC) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712211245im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. Also available in French from the <a href="/web/20180712211245/https://www.guideline.gov/Home/Disclaimer?id=47083&amp;contentType=summary&amp;redirect=http%3a%2f%2fsogc.org%2ffr%2fguidelines%2fintrauterine-growth-restriction-screening-diagnosis-management%2f" title="Society of Obstetricians and Gynaecologists of Canada (SOGC) Web site">SOGC Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712211245im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p>
<p>Print copies: Available from the Society of Obstetricians and Gynaecologists of Canada, La soci&eacute;t&eacute; des obst&eacute;triciens et gyn&eacute;cologues du Canada (SOGC) 780 promenade Echo Drive Ottawa, ON K1S 5R7 (Canada); Phone: 1-800-561-2416.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on November 19, 2013. The information was verified by the guideline developer on December 13, 2013.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712211245/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712211245/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712211245/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712211245/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712211245/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712211245/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712211245/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712211245/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712211245/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712211245/https://www.guideline.gov/disclaimer?id=47083&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712211245/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712211245/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712211245/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712211245/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712211245/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712211245/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712211245/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712211245/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712211245/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712211245/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712211245/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712211245/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712211245/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712211245im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712211245/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712211245/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712211245js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712211245js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 21:12:45 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:50:02 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 799.077 (3)
  esindex: 0.009
  captures_list: 824.295
  CDXLines.iter: 18.69 (3)
  PetaboxLoader3.datanode: 105.201 (4)
  exclusion.robots: 0.169
  exclusion.robots.policy: 0.159
  RedisCDXSource: 1.716
  PetaboxLoader3.resolve: 388.669 (3)
  load_resource: 45.404
-->